ErbB4 rs1595066 creates a binding site for miR-200*, a member of miR-200 tumor-suppressor miRNAs, and is associated with a lower EC risk, probably through the downregulation of ErbB4 [42]. The gene discussed is ERBB4; the disease is neoplasm.